Leaflet MIFEPRISTONA LINEPHARMA 200mg tablets

Product code:
W60887001
Quantity:
1
Indicated for:
medical termination of pregnancy
Route of administration:
oral
Substance:
mifepristone (hormone)
ATC
G03XB01 — Genito urinary system and sex hormones | Other sex hormones and modulators of the genital system | Progesterone receptor modulators

Precautions:

Breastfeeding warning

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Mifepristone is a medication used for terminating early pregnancies, typically up to 10 weeks of gestation. It acts as a progesterone receptor antagonist, blocking the effects of this hormone essential for maintaining pregnancy.

The medication is taken orally under medical supervision and is often used in combination with misoprostol to increase effectiveness. It is effective in inducing medical abortion.

Side effects may include nausea, vomiting, abdominal cramps, and vaginal bleeding. In rare cases, severe complications such as infections or hemorrhage may occur. Close monitoring is essential.

Consult your doctor to discuss the benefits and risks of treatment with Mifepristone. This medication must be used exclusively under medical supervision.

General data about MIFEPRISTONA LINEPHARMA 200mg

Substance:
mifepristone
Date of latest medicines list:
01-07-2020
Product code:
W60887001
Concentration:
200mg
Pharmaceutical form:
tablets
Quantity:
1
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
LABORATORIOS LEON FARMA, S.A. - SPANIA
Holder:
LINEPHARMA INTERNATIONAL LIMITED - MAREA BRITANIE
Number:
8866/2016/01
Shelf life:
3 years

Concentrations available for mifepristone

  • 200mg
  • 600mg

Combinations with other substances